Adicet Bio (ACET) Financials

$9.59

$0.16 (1.70%)

As on 04-Sep-2026 16:00EDT

Market cap

$85 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Jun-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20
Operating Revenue	--	--	--	--	24.99	24.99
Cost of Revenue	4.42	6.38	6.47	6.10	--	5.01
Gross Profit	-4.42	-6.38	-6.47	-6.10	24.99	24.99
Operating Expenses	102.37	115.73	127.62	152.04	97.54	97.54
Operating Profit (EBIT)	-103.71	-122.11	-127.62	-152.04	-72.55	-72.55
Other Income	--	--	--	--	--	--
Profit before Tax	-98.83	-116.80	-117.12	-142.66	-69.79	-69.79
Provision for Tax	0.14	--	--	5.93	-2.76	-2.76
Profit after Tax (Net Income)	-98.97	-116.80	-117.12	-142.66	-67.03	-69.79
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-69.79	--

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Jun-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20
Shareholder's Funds	120.14	159.21	186.61	170.18	-238.11	292.34
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	10.03	11.61	14.22	17.83	18.65	18.65
Current Liabilities	18.00	21.53	19.39	19.29	19.71	19.71
Total Liabilities	166.17	192.36	220.22	207.30	330.69	330.69

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Jun-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20
Non-Current Assets	27.40	31.43	40.08	45.02	69.65	69.65
Current Assets	120.76	160.93	180.14	162.27	261.04	261.04
Total Assets	166.17	192.36	220.22	207.30	-199.76	330.69
Total Debt*	12.85	14.74	17.23	20.92	21.02	21.02
Net Current Assets	102.76	139.40	160.74	142.99	241.33	241.33

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Jun-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20
Cash From Operating Activities	--	-95.25	-92.38	-93.72	-44.77	-44.77
Cash Flow from Investing Activities	--	2.39	-119.24	-4.46	-16.78	-16.78
Cash from Financing Activities	--	75.25	111.31	0.24	41.51	41.51
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Jun-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20
Adjusted EPS ($)	-13.02	-16.95	-21.33	-53.04	-1.56	-26.81
Cash EPS ($)	--	-16.02	-20.15	-50.77	-1.50	-25.82
Adjusted Book Value ($)	--	23.10	33.98	63.27	--	112.30
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-13.82	-16.82	-34.84	-1.04	-17.20
Free Cash Flow per Share ($)	--	-14.07	-17.02	-36.50	-1.43	-23.64

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Jun-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20
ROCE (%)	--	-61.83	-59.31	1,097.71	36.78	-84.09
ROE (%)	-70.86	-67.55	-65.65	419.96	32.98	-112.55
ROA (%)	-57.17	-56.62	-54.79	-53.03	-20.02	-20.84
EBIT Margin (%)	--	--	--	--	-290.32	-278.95
Net Margin (%)	--	--	--	--	-268.22	-279.27
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Jun-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20
Revenue Growth (%)	--	--	--	-1.00	1.57	1.57
EBIT Growth (%)	16.76	0.30	17.89	-104.61	-18.10	-12.53
Net Profit Growth (%)	16.57	0.27	17.90	-104.41	-8.11	-12.57
EPS Growth (%)	38.13	0.21	0.60	-0.98	-0.01	0.08
Book Value Growth (%)	-52.28	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Jun-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20
Price / Earnings	--	-0.50	-0.05	-0.04	-1.56	-0.33
Price / Book Value	0.70	0.36	0.03	0.03	-0.44	0.08
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.21	0.78	1.39	0.98	1.90	3.30
Close Price ($)	8.64	8.42	15.39	30.24	38.88	143.04
High Price ($)	17.44	17.76	60.32	152.40	349.92	349.92
Low Price ($)	6.01	7.15	12.96	17.60	31.68	120.96
Market Cap ($ Cr)	84.82	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Jun-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20
Debt to Equity	--	0.09	0.09	0.12	-0.09	0.07
Short term debt to equity ratio	0.02	0.02	0.02	0.02	-0.01	0.01
Current Ratio	6.71	7.47	9.29	8.41	13.25	13.25
Quick Ratio	6.71	--	--	--	13.12	13.12
Interest Coverage	-1,219.14	-3,243.53	-29,279.50	-5,705.32	-906.89	-871.38

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Jun-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20
Debtors to sales (%)	--	--	--	--	1.74	1.74
Asset Turnover	--	--	--	--	0.07	0.07
Receivable days	--	--	--	--	4.74	4.74
Inventory Days	--	--	--	153.75	--	264.15
Payable days	--	273.87	210.49	210.51	--	279.53
Cash Conversion Cycle	--	--	--	--	--	-10.64

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.